RedHill Biopharma (IMAGE)

RedHill Biopharma

RedHill Biopharma

Caption

RedHill's opaganib mechanism unaffected by Omicron mutations

Credit

RedHill Biopharma

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.